Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ARK Venture FundNONE · Entity 30177 | Trustee | August 15, 2022 | August 16, 2022 |
| LGL GROUP INCLGL · Entity 6820 | Director | March 26, 2026 | March 30, 2026 |
| Longevity Health Holdings, Inc.ALPA · Entity 8659 | Director | July 26, 2021 | July 27, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ARK Venture Fund
Report date August 15, 2022 · Filed August 16, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Shares of beneficial interestSEC Table I · non-derivative | Direct | 0 |
Reported balance
Holding disclosure · report date 2022-08-15 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 0 |
LGL GROUP INC
Report date March 26, 2026 · Filed March 30, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 7,249 |
Reported balance
After 2026-03-26 transaction · row 1
1 source rowRow 1 · 2026-03-26 · Grant · Acquired 2,067 · Balance 7,249 F1: These shares vest 3 years from the date of grant, on 3/26/2029. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares vest 3 years from the date of grant, on 3/26/2029.
Longevity Health Holdings, Inc.
Report date July 26, 2021 · Filed July 27, 2021
This filing explicitly reported no securities owned.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 26, 2026 Filed Mar 30, 2026 23:25 UTC | LGL GROUP INC LGL · Entity 6820 | GrantCommon Stock | 2,067 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-26-010417 · rdgdoc.xml · nonDerivative · entry 1 DeRemer Darlene T. · CIK 0001312040 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,249 F1 · shares: These shares vest 3 years from the date of grant, on 3/26/2029. Read SEC document |
| March 25, 2025 Filed Mar 27, 2025 21:23 UTC | LGL GROUP INC LGL · Entity 6820 | GrantCommon Stock | 2,308 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-009652 · rdgdoc.xml · nonDerivative · entry 1 DeRemer Darlene T. · CIK 0001312040 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,182 F1 · shares: These shares vest 3 years from the date of grant, on 3/25/2028. Read SEC document |
| December 08, 2023 Filed Dec 12, 2023 19:36 UTC | LGL GROUP INC LGL · Entity 6820 | GrantCommon Stock | 2,874 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-034169 · rdgdoc.xml · nonDerivative · entry 1 DeRemer Darlene T. · CIK 0001312040 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,874 F1 · shares: These shares vest 3 years from the date of grant, on 12/8/2026. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.